APA (7th ed.) Citation

Guerin, M., Rezai, K., Isambert, N., Campone, M., Autret, A., Pakradouni, J., . . . Gonçalves, A. (2017). PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer. European Journal of Cancer, 86, 28. https://doi.org/10.1016/j.ejca.2017.08.025

Chicago Style (17th ed.) Citation

Guerin, Mathilde, et al. "PIKHER2: A Phase IB Study Evaluating Buparlisib in Combination with Lapatinib in Trastuzumab-resistant HER2-positive Advanced Breast Cancer." European Journal of Cancer 86 (2017): 28. https://doi.org/10.1016/j.ejca.2017.08.025.

MLA (9th ed.) Citation

Guerin, Mathilde, et al. "PIKHER2: A Phase IB Study Evaluating Buparlisib in Combination with Lapatinib in Trastuzumab-resistant HER2-positive Advanced Breast Cancer." European Journal of Cancer, vol. 86, 2017, p. 28, https://doi.org/10.1016/j.ejca.2017.08.025.